Literature DB >> 32274803

Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex.

Nicholas Rensing1, Kevin J Johnson1, Thomas J Foutz1, Joseph L Friedman1, Rafael Galindo1, Michael Wong1.   

Abstract

OBJECTIVE: Tuberous sclerosis complex (TSC) is one of the most common genetic causes of epilepsy. Seizures in TSC typically first present in infancy or early childhood, including focal seizures and infantile spasms. Infantile spasms in TSC are particularly characteristic in its strong responsiveness to vigabatrin. Although a number of mouse models of epilepsy in TSC have been described, there are very limited electroencephalographic (EEG) or seizure data during the preweanling neonatal and infantile-equivalent mouse periods. Tsc1GFAP CKO mice are a well-characterized mouse model of epilepsy in TSC, but whether these mice have seizures during early development has not been documented. The objective of this study was to determine whether preweanling Tsc1GFAP CKO mice have developmental EEG abnormalities or seizures, including spasms.
METHODS: Longitudinal video-EEG and electromyographic recordings were performed serially on Tsc1GFAP CKO and control mice from postnatal days 9-21 and analyzed for EEG background abnormalities, sleep-wake vigilance states, and spontaneous seizures. Spasms were also induced with varying doses of N-methyl-D-aspartate (NMDA).
RESULTS: The interictal EEG of Tsc1GFAP CKO mice had excessive discontinuity and slowing, suggesting a delayed developmental progression compared with control mice. Tsc1GFAP CKO mice also had increased vigilance state transitions and fragmentation. Tsc1GFAP CKO mice had spontaneous focal seizures in the early neonatal period and a reduced threshold for NMDA-induced spasms, but no spontaneous spasms were observed. SIGNIFICANCE: Neonatal Tsc1GFAP CKO mice recapitulate early developmental aspects of EEG abnormalities, focal seizures, and an increased propensity for spasms. This mouse model may be useful for early mechanistic and therapeutic studies of epileptogenesis in TSC.
© 2020 International League Against Epilepsy.

Entities:  

Keywords:  EEG; electroencephalography; epilepsy; infantile spasms; seizure; tuberous sclerosis

Mesh:

Substances:

Year:  2020        PMID: 32274803      PMCID: PMC9417212          DOI: 10.1111/epi.16495

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   6.740


  41 in total

1.  Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.

Authors:  Bo Zhang; Jia Zou; Nicholas R Rensing; Meihua Yang; Michael Wong
Journal:  Neurobiol Dis       Date:  2015-05-21       Impact factor: 5.996

2.  Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.

Authors:  Laura Magri; Marco Cambiaghi; Manuela Cominelli; Clara Alfaro-Cervello; Marco Cursi; Mauro Pala; Alessandro Bulfone; Jose Manuel Garcìa-Verdugo; Letizia Leocani; Fabio Minicucci; Pietro Luigi Poliani; Rossella Galli
Journal:  Cell Stem Cell       Date:  2011-11-04       Impact factor: 24.633

3.  Epilepsy in young Tsc1(+/-) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex.

Authors:  Svetlana Gataullina; Eric Lemaire; Fabrice Wendling; Anna Kaminska; Françoise Watrin; Audrey Riquet; Dorothée Ville; Marie-Laure Moutard; Anne de Saint Martin; Silvia Napuri; Jean-Michel Pedespan; Monika Eisermann; Nadia Bahi-Buisson; Rima Nabbout; Catherine Chiron; Olivier Dulac; Gilles Huberfeld
Journal:  Epilepsia       Date:  2016-02-13       Impact factor: 5.864

4.  Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.

Authors:  Darcy A Krueger; Angus A Wilfong; Katherine Holland-Bouley; Anne E Anderson; Karen Agricola; Cindy Tudor; Maxwell Mays; Christina M Lopez; Mi-Ok Kim; David Neal Franz
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

5.  Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.

Authors:  David M Feliciano; Tiffany Su; Jean Lopez; Jean-Claude Platel; Angélique Bordey
Journal:  J Clin Invest       Date:  2011-03-14       Impact factor: 14.808

6.  The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.

Authors:  Ebru Erbayat-Altay; Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

7.  Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.

Authors:  Jacqueline A French; John A Lawson; Zuhal Yapici; Hiroko Ikeda; Tilman Polster; Rima Nabbout; Paolo Curatolo; Petrus J de Vries; Dennis J Dlugos; Noah Berkowitz; Maurizio Voi; Severine Peyrard; Diana Pelov; David N Franz
Journal:  Lancet       Date:  2016-09-06       Impact factor: 79.321

8.  Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.

Authors:  Bo Zhang; Jia Zou; Lirong Han; Nicholas Rensing; Michael Wong
Journal:  Epilepsia       Date:  2016-06-06       Impact factor: 5.864

9.  Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.

Authors:  Jia Zou; Bo Zhang; David H Gutmann; Michael Wong
Journal:  Epilepsia       Date:  2017-10-12       Impact factor: 5.864

10.  Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.

Authors:  N Lozovaya; S Gataullina; T Tsintsadze; V Tsintsadze; E Pallesi-Pocachard; M Minlebaev; N A Goriounova; E Buhler; F Watrin; S Shityakov; A J Becker; A Bordey; M Milh; D Scavarda; C Bulteau; G Dorfmuller; O Delalande; A Represa; C Cardoso; O Dulac; Y Ben-Ari; N Burnashev
Journal:  Nat Commun       Date:  2014-08-01       Impact factor: 14.919

View more
  2 in total

Review 1.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

2.  An Epilepsy-Associated Mutation of Salt-Inducible Kinase 1 Increases the Susceptibility to Epileptic Seizures and Interferes with Adrenocorticotropic Hormone Therapy for Infantile Spasms in Mice.

Authors:  Bo Pang; Takuma Mori; Moataz Badawi; Mengyun Zhou; Qi Guo; Emi Suzuki-Kouyama; Toru Yanagawa; Yoshinori Shirai; Katsuhiko Tabuchi
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.